Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a16109b9c2952f6af6b6dac6390e804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8138bbcef49a9847a3edebd33b503dd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e20e6a9414fd6dbd4c46fc839e30b2b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4a74a1769b7dc509ff685232981ba88 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0002 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b258243daf2d43371d5df8123749ed81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63fc1a826edc54a5a6f4191bb9833b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eefb2badc7e14617ca67b6fb15ea970 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b6d936a16d10fbc328b31982cad1c2 |
publicationDate |
2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009269355-A1 |
titleOfInvention |
Catalytic antibodies and a method of producing same |
abstract |
The present invention relates generally to a growth factor precursor and its use to select production of antigen specific catalytic antibodies. Such catalytic antibodies are produced following B cell activation and proliferation induced by catalytic cleavage products of a target antigen portion of the growth factor precursor of the present invention. A particularly useful form of the growth factor precursor is as a nucleic acid vaccine. The nucleic acid vaccine of the present invention preferably further comprises a molecular adjuvant. Another aspect of the present invention comprises a growth factor precursor in multimeric form. The growth factor precursor of the present invention is useful for generating catalytic antibodies for both therapeutic, diagnostic and industrial purposes. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201104-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9534040-B2 |
priorityDate |
1997-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |